FDA approves Immucor’s PreciseType® HEA Test to be used for screening blood donors for Sickle Cell Trait (SCT)
October 21, 2016 17:10 ET
|
Immucor, Inc.
Now recognized as a tool to identify SCT negative units in addition to extended antigen typings all in one test Reduces the time and expense of selecting units for patients requiring frequent...
Immucor to Host Debt Investor Conference Call on Friday, October 21, 2016
October 17, 2016 17:41 ET
|
Immucor, Inc.
NORCROSS, Ga., Oct. 17, 2016 (GLOBE NEWSWIRE) -- Immucor, Inc., a global leader in transfusion and transplantation diagnostics, today announced that it will hold a conference call with debt...
Immucor to Host Debt Investor Conference Call on Wednesday, September 7, 2016
August 22, 2016 17:04 ET
|
Immucor, Inc.
NORCROSS, Ga., Aug. 22, 2016 (GLOBE NEWSWIRE) -- Immucor, Inc., a global leader in transfusion and transplantation diagnostics, today announced that it will hold a conference call with debt...
Immucor Announces the Launch of kSORT™ to Support the Health of Kidney Transplant Recipients
May 02, 2016 14:18 ET
|
Immucor, Inc.
NORCROSS, Ga., May 02, 2016 (GLOBE NEWSWIRE) -- Immucor, Inc., a global leader in transfusion and transplantation diagnostics, announced today the launch of its kidney Solid Organ Response Test,...
Immucor to Host Debt Investor Conference Call on Thursday, April 21, 2016
April 13, 2016 09:19 ET
|
Immucor, Inc.
NORCROSS, Ga., April 13, 2016 (GLOBE NEWSWIRE) -- Immucor, Inc., a global leader in transfusion and transplantation diagnostics, today announced that it will hold a conference call with debt...
Medicare Administrative Contractors Finalize Local Coverage Determinations for Immucor PreciseType® HEA Test
April 04, 2016 16:08 ET
|
Immucor, Inc.
NORCROSS, Ga., April 04, 2016 (GLOBE NEWSWIRE) -- Immucor, Inc., a global leader in transfusion and transplantation diagnostics, announced that Medicare Administrative Contractors (MACs) that...
Immucor’s ImmuLINK® Software Suite v1.7 Receives FDA Clearance to Interface with PreciseType™ HEA
March 21, 2016 15:52 ET
|
Immucor, Inc.
NORCROSS, Ga., March 21, 2016 (GLOBE NEWSWIRE) -- Immucor, Inc., a global leader in transfusion and transplantation diagnostics, today announced FDA clearance for the latest release of ImmuLINK®...
Immucor Acquires Sirona Genomics
March 04, 2016 17:08 ET
|
Immucor, Inc.
Transaction culminates successful collaboration to bring MIA FORA™ NGS offering for high resolution HLA typing to market NORCROSS, Ga., March 04, 2016 (GLOBE NEWSWIRE) -- Immucor, Inc., a global...
Immucor and Sirona Genomics Announce CE Mark for MIA FORA™ NGS HLA Typing Solution
February 03, 2016 11:41 ET
|
Immucor, Inc.
NORCROSS, Ga., Feb. 03, 2016 (GLOBE NEWSWIRE) -- Immucor, Inc., a global leader in transfusion and transplantation diagnostics, in collaboration with Sirona Genomics, today announced CE Mark...
Immucor to Host Debt Investor Conference Call on Tuesday, February 2, 2016
January 14, 2016 17:28 ET
|
Immucor, Inc.
NORCROSS, Ga., Jan. 14, 2016 (GLOBE NEWSWIRE) -- Immucor, Inc., a global leader in transfusion and transplantation diagnostics, today announced that it will hold a conference call with debt...